Tillman U. Gerngross

Insider Reports History

Entity
Individual
Location
C/O Arsanis, Inc., 890 Winter Street, Suite 230, Waltham, MA
Signature
/s/ Marc Grasso, by power of attorney
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Tillman U. Gerngross:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Adagio Therapeutics, Inc. Chief Executive Officer, Director, 10%+ Owner Common Stock 27.8M $110M $3.95 Aug 10, 2021 Indirect
Alector, Inc. Director Common Stock 2.64M $14.7M $5.56 Jun 14, 2023 Direct
Adagio Therapeutics, Inc. Chief Executive Officer, Director, 10%+ Owner Stock Option (Right to Buy) 175K Jan 30, 2022 Direct
Alector, Inc. Director Stock Option (right to buy) 12.4K Jun 14, 2023 Direct
Adagio Therapeutics, Inc. Chief Executive Officer, Director, 10%+ Owner Series A Preferred Stock 0 Aug 10, 2021 Indirect
Adagio Therapeutics, Inc. Chief Executive Officer, Director, 10%+ Owner Series B Preferred Stock 0 Aug 10, 2021 Indirect
Adagio Therapeutics, Inc. Chief Executive Officer, Director, 10%+ Owner Series C Preferred Stock 0 Aug 10, 2021 Indirect

Insider Reports Filed by Tillman U. Gerngross

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ALEC Alector, Inc. Jun 14, 2023 2 $0 4 Jun 15, 2023 Director
ALEC Alector, Inc. Jun 16, 2022 2 $0 4 Jun 21, 2022 Director
IVVD Adagio Therapeutics, Inc. Jan 30, 2022 1 $0 4 Feb 1, 2022 Chief Executive Officer, Director, 10%+ Owner
IVVD Adagio Therapeutics, Inc. Aug 10, 2021 4 $0 4 Aug 12, 2021 Chief Executive Officer, Director, 10%+ Owner
IVVD Adagio Therapeutics, Inc. Aug 5, 2021 0 $0 3 Aug 5, 2021 Chief Executive Officer, Director, 10%+ Owner
ALEC Alector, Inc. Jun 17, 2021 1 $0 4 Jun 22, 2021 Director